Results 111 to 120 of about 185,056 (259)

Establishment and characterization of mouse lymph node fibrosis models

Animal Models and Experimental Medicine, EarlyView.
The design of the entire paper. Schematic illustration of four strategies for establishing mouse lymph node (LN) fibrosis models. The study further compares their fibrotic remodeling patterns and immune alterations. Abstract Background Lymph node (LN) fibrosis occurs in a variety of pathological conditions, including HIV infection, obesity, cancer, and
Yaru Niu, Xu Guan, Jian Ma, Xin Zhang, Yihang Shi, Jinzhu Zhang, Leiqiong Gao, Wei Chen, Xishan Wang   +8 more
wiley   +1 more source

Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy. [PDF]

J Med Virol
Shiue SJ, Ho TH, Lin HY, Cheng SW, Wu LW, Chan TS, Chen CN, Cheng CL, Lee YK, Yang HY, Shiue HS, Leng KF, Wu MS.   +12 more
europepmc   +1 more source

Mitochondrial quality control: a new mechanism for antiviral therapy. [PDF]

Front Immunol
Duan X, Lan W, Liu R, Zhang P, Chen S, Zhang Y, Zhang L, Li H, Liu S.   +8 more
europepmc   +1 more source

Maintaining versus switching antiviral therapy in chronic hepatitis B patients with low-level viremia. [PDF]

J Virus Erad
Wang Y, Li L, Song C, Zhou J, Li Y, Sahar M, Wang M, Tao Y, Zhou T, He F, Lu J, Lei X, Chen E.   +12 more
europepmc   +1 more source

Discovery of an Antiviral Electron Transfer Process to Create Catalytically Self‐Sufficient Viral Restriction Factors

Angewandte Chemie International Edition, EarlyView.
CYB5R3 is identified as a putative electron‐transfer partner of viperin (RSAD2), explaining why ER localisation is required for antiviral activity. Its utilisation enabled the engineering of immune‐silent, catalytically self‐sufficient antiviral restriction factor enzymes (iCAREs) that produce an antiviral nucleoside triphosphate analogue (ANTA ...
Mengdi Wu, Nghi Thao Hoang, Deborah Grifagni, Meritxell Wu‐Lu, Yujie Sheng, Theo Situmorang, Pei‐Hsin Tai, Zheng Chen, Astrid Maluta, Mohammed Hakil, Bianca Susini, Hannah Florance, Peter‐Leon Hagedoorn, John Mark Sutton, Maria‐Andrea Mroginski, Simone Ciofi‐Baffoni, Kourosh H. Ebrahimi   +16 more
wiley   +1 more source

Antiviral therapy and the risk of extrahepatic malignancies in chronic hepatitis C: insights from recent evidence. [PDF]

Transl Cancer Res
Kanda T, Sasaki-Tanaka R, Terai S.
europepmc   +1 more source

Establishment of an oral enterovirus 71 (EV71) infection model in immunocompetent mice for antiviral therapy evaluation. [PDF]

J Virol
Ma Y, Luo D, Ke X, Song X, Hao M, Chen J, Zhang Y.   +6 more
europepmc   +1 more source

Impact of Early COVID-19 Antiviral Therapy on the Incidence of Uveitis: A Retrospective Cohort Study Using the TriNetX Database. [PDF]

Immun Inflamm Dis
Kuo HT, Hsu AY, Liu DY, Wu BQ, Wei JC, Hsia NY, Shao YC, Lai CT, Chiang CC, Lin CJ, Chen HS, Wang YH, Tseng H, Hsu HC, Tsai YY.   +14 more
europepmc   +1 more source

Maternal Cytomegalovirus Viral Load Correlates With the Risk of Congenital Infection and With Antiviral Therapy Response in Early Pregnancy. [PDF]

Open Forum Infect Dis
Egloff C, Vauloup Fellous C, Houhou-Fidouh N, Benachi A, Mandelbrot L, Vivanti AJ, Picone O.   +6 more
europepmc   +1 more source

Chicken Pulmonary MicroRNAs Targeting the PB2 (Segment 1) of Avian Influenza Virus

Animal Research and One Health, EarlyView.
The PB2 segment of H5N1 is essential for replication and host adaptation. We screened 200 miRNAs and identified five (gga‐miR‐17‐3p, gga‐miR‐29a‐5p, gga‐miR‐1718, gga‐miR‐16c‐5p, and gga‐miR‐1744‐5p) using thermodynamic stability of heteroduplex, seed sequence complementarity, conservation, and accessibility, offering insights into host antiviral ...
Akanksha Choudhary, Nidhishree N. S, Rakesh Kumar Pundir, Muhasin Asaf V. N, Anamika Mishra, Ashwin Ashok Raut, Megha Agarwal, Amod Kumar   +7 more
wiley   +1 more source